Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal-Onset Seizure”

207 trials

Showing 20 of 207 results

Not applicableEnded earlyNCT04839601
What this trial is testing

RNS System RESPONSE Study

Who this might be right for
EpilepsyPartial SeizureNeurostimulator; Complications+2 more
NeuroPace 9
Testing effectiveness (Phase 2)Study completedNCT02899611
What this trial is testing

A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures

Who this might be right for
Epilepsy
Cerebral Therapeutics LLC 6
Large-scale testing (Phase 3)Looking for participantsNCT06132893
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Testing effectiveness (Phase 2)Study completedNCT02914314
What this trial is testing

Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Who this might be right for
Epilepsy
Eisai Inc. 26
Not applicableStudy completedNCT05747001
What this trial is testing

This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK

Who this might be right for
Focal Onset SeizureEpilepsy
Aziende Chimiche Riunite Angelini Francesco S.p.A 319
Not applicableLooking for participantsNCT06716801
What this trial is testing

Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

Who this might be right for
Focal Epilepsy With and Without Secondary Generalization
Aziende Chimiche Riunite Angelini Francesco S.p.A 300
Early research (Phase 1)Looking for participantsNCT04903314
What this trial is testing

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 24
Early research (Phase 1)Study completedNCT01355068
What this trial is testing

Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia

Who this might be right for
Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 26
Post-approval studies (Phase 4)Study completedNCT01278173
What this trial is testing

The Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

Who this might be right for
Adult Refractory Complex Partial Seizures
Lundbeck LLC 65
Large-scale testing (Phase 3)Study completedNCT00699582
What this trial is testing

To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 389
Large-scale testing (Phase 3)Study completedNCT00151879
What this trial is testing

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Who this might be right for
Epilepsies, Partial
UCB Pharma 160
Testing effectiveness (Phase 2)Study completedNCT00368472
What this trial is testing

4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Inc. 138
Large-scale testing (Phase 3)Study completedNCT00136019
What this trial is testing

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Who this might be right for
Epilepsy
UCB Pharma 400
Large-scale testing (Phase 3)Ended earlyNCT00372528
What this trial is testing

An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures

Who this might be right for
Epilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 21
Large-scale testing (Phase 3)Study completedNCT00143143
What this trial is testing

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Who this might be right for
Epilepsies, PartialEpilepsy, Complex Partial
Pfizer 300
Post-approval studies (Phase 4)Ended earlyNCT01546688
What this trial is testing

Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Limited 41
Testing effectiveness (Phase 2)Ended earlyNCT04529954
What this trial is testing

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

Who this might be right for
Focal Epilepsy
Cerebral Therapeutics LLC 20
Post-approval studies (Phase 4)Study completedNCT03712475
What this trial is testing

Pharmacokinetics of Two Formulation of Pregabalin

Who this might be right for
Diabetic Peripheral NeuropathyFibromyalgiaPartial Seizure Disorder
Yung Shin Pharm. Ind. Co., Ltd. 28
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06443463
What this trial is testing

Long-term Safety and Tolerability of BHV-7000

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 660
Testing effectiveness (Phase 2)Study completedNCT00849212
What this trial is testing

An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)

Who this might be right for
Refractory Partial Seizures
Eisai Co., Ltd. 30
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation